• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海参岩藻聚糖通过MAPK/NF-κB信号通路和肠道微生物群调节抑制胃炎。

Sea Cucumber Fucoidan Inhibits Gastritis via MAPK/NF-κB Signaling and Gut Microbiota Modulation.

作者信息

Cao Junhan, Yao Mengke, Wang Kai, Qin Ling, Zhang Qing, Zhang Haibo, Wei Jinzheng, Qu Changfeng, Xue Changhu, Miao Jinlai

机构信息

College of Food Science and Engineering, Ocean University of China, Qingdao 266003, China.

Qingdao Key Laboratory of Marine Natural Products Research and Development Laboratory, First Institute of Oceanography, Ministry of Natural Resources, Qingdao 266061, China.

出版信息

J Agric Food Chem. 2025 Jun 11;73(23):14333-14352. doi: 10.1021/acs.jafc.5c02190. Epub 2025 May 30.

DOI:10.1021/acs.jafc.5c02190
PMID:40444701
Abstract

Antibiotic-based eradication therapy for faces challenges such as the increasing number of antibiotic-resistant strains and gut microbiota dysbiosis. The study evaluated the effects of fucoidan from sea cucumber cooking liquid (Fuc-SC) on (Hp SS1)-associated gastritis. The backbone structure of Fuc-SC was composed of alternating → 3)-α-L-Fuc-(1 → 4)-α-L-Fuc-(1 → linked fucose residues. The mouse experiments demonstrated that Fuc-SC reduced the colonization of Hp SS1 in the gastric mucosa through decreasing the level of urease, Hp-IgG, and CagA-IgG. In addition, Fuc-SC regulated oxidative stress levels by reducing NO, MDA, and ROS levels, while increasing the activity of SOD and GSH-Px. Compared to antibiotic treatment alone, the combination of Fuc-SC with antibiotics further enhanced the antioxidant effects. Molecular mechanisms indicated that Fuc-SC regulated the MAPK/NF-κB signaling pathway, downregulating the expression of inflammatory factors such as IL-1β and TNF-α and further modulating the expression of S100A8 and E-cadherin. Gut microbiota analysis indicated that Fuc-SC reversed the depletion of caused by antibiotic treatment. Additionally, Fuc-SC significantly promoted the biosynthesis of microbial metabolites such as butyric acid, isobutyric acid, hexanoic acid, and phospholipids, thereby alleviating inflammation. These findings highlight its potential as a sustainable, nonantibiotic therapy for -associated gastritis.

摘要

基于抗生素的根除疗法面临着诸如抗生素耐药菌株数量增加和肠道微生物群失调等挑战。该研究评估了海参蒸煮液中的岩藻聚糖(Fuc-SC)对幽门螺杆菌(Hp SS1)相关性胃炎的影响。Fuc-SC的主链结构由交替的→3)-α-L-岩藻糖-(1→4)-α-L-岩藻糖-(1→连接的岩藻糖残基组成。小鼠实验表明,Fuc-SC通过降低脲酶、Hp-IgG和CagA-IgG水平,减少了Hp SS1在胃黏膜中的定植。此外,Fuc-SC通过降低NO、MDA和ROS水平,同时增加SOD和GSH-Px的活性来调节氧化应激水平。与单独使用抗生素治疗相比,Fuc-SC与抗生素联合使用进一步增强了抗氧化作用。分子机制表明,Fuc-SC调节MAPK/NF-κB信号通路,下调IL-1β和TNF-α等炎症因子的表达,并进一步调节S100A8和E-钙黏蛋白的表达。肠道微生物群分析表明,Fuc-SC逆转了抗生素治疗引起的某种微生物的减少。此外,Fuc-SC显著促进了丁酸、异丁酸、己酸和磷脂等微生物代谢产物的生物合成,从而减轻了炎症。这些发现突出了其作为幽门螺杆菌相关性胃炎的可持续、非抗生素疗法的潜力。

相似文献

1
Sea Cucumber Fucoidan Inhibits Gastritis via MAPK/NF-κB Signaling and Gut Microbiota Modulation.海参岩藻聚糖通过MAPK/NF-κB信号通路和肠道微生物群调节抑制胃炎。
J Agric Food Chem. 2025 Jun 11;73(23):14333-14352. doi: 10.1021/acs.jafc.5c02190. Epub 2025 May 30.
2
Fucoidan from sea cucumber cooking liquid: Structural analysis, physicochemical properties, and anti-Helicobacter pylori potential.海参蒸煮液中的岩藻依聚糖:结构分析、理化性质及抗幽门螺杆菌潜力
Int J Biol Macromol. 2025 May;306(Pt 4):141593. doi: 10.1016/j.ijbiomac.2025.141593. Epub 2025 Feb 28.
3
Zuojin Pill attenuates Helicobacter pylori-induced chronic atrophic gastritis in rats and improves gastric epithelial cells function in GES-1 cells.左金丸减轻幽门螺杆菌诱导的大鼠慢性萎缩性胃炎和改善 GES-1 细胞胃上皮细胞功能。
J Ethnopharmacol. 2022 Mar 1;285:114855. doi: 10.1016/j.jep.2021.114855. Epub 2021 Nov 20.
4
Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people.幽门螺杆菌阳性人群消化性溃疡疾病的根除治疗。
Cochrane Database Syst Rev. 2016 Apr 19;4(4):CD003840. doi: 10.1002/14651858.CD003840.pub5.
5
Gastric cancer risk after Helicobacter pylori eradication in gastritis and peptic ulcer: a retrospective cohort study in Japan.胃炎和消化性溃疡患者根除幽门螺杆菌后的胃癌风险:日本的一项回顾性队列研究
BMC Gastroenterol. 2025 Jul 1;25(1):463. doi: 10.1186/s12876-025-04034-3.
6
Sequential versus standard triple first-line therapy for Helicobacter pylori eradication.用于根除幽门螺杆菌的序贯疗法与标准三联一线疗法对比
Cochrane Database Syst Rev. 2016 Jun 28;2016(6):CD009034. doi: 10.1002/14651858.CD009034.pub2.
7
Helicobacter pylori and gastric or duodenal ulcer.幽门螺杆菌与胃或十二指肠溃疡。
Prescrire Int. 2016 Jan;25(167):18-23.
8
Hydrogel-Transformable Probiotic Powder for Targeted Eradication of Helicobacter pylori with Enhanced Gastric Mucosal Repair and Microbiota Preservation.用于靶向根除幽门螺杆菌、增强胃黏膜修复和保护微生物群的水凝胶可转化益生菌粉。
Adv Sci (Weinh). 2025 Jun;12(23):e2500478. doi: 10.1002/advs.202500478. Epub 2025 Mar 16.
9
Effects of amoxicillin dosage on cure rate, gut microbiota, and antibiotic resistome in vonoprazan and amoxicillin dual therapy for Helicobacter pylori: a multicentre, open-label, non-inferiority randomised controlled trial.阿莫西林剂量对伏诺拉生和阿莫西林联合治疗幽门螺杆菌的治愈率、肠道微生物群及抗生素耐药组的影响:一项多中心、开放标签、非劣效性随机对照试验
Lancet Microbe. 2025 Mar;6(3):100975. doi: 10.1016/j.lanmic.2024.100975. Epub 2024 Dec 18.
10
Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori?系统评价:益生菌对控制幽门螺杆菌在胃内的定植是否有用?
Aliment Pharmacol Ther. 2006 Apr 15;23(8):1077-86. doi: 10.1111/j.1365-2036.2006.02868.x.

引用本文的文献

1
Fucoidan as a therapeutic agent for ulcerative colitis: mechanisms of action and modulation of the gut microbiota.岩藻依聚糖作为溃疡性结肠炎的治疗剂:作用机制及对肠道微生物群的调节
Front Cell Infect Microbiol. 2025 Jul 10;15:1626614. doi: 10.3389/fcimb.2025.1626614. eCollection 2025.